Skip to content

SMAART-J: a short-term music therapy intervention to promote attention and arousal regulation in youth with trauma symptoms in specialized youth care.

SMAART-J: a short-term music therapy intervention to promote attention and arousal regulation in youth with trauma symptoms in specialized youth care. - SMAART-J

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON57776
Enrollment
20
Registered
2024-10-30
Start date
2026-06-02
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

focused and sustained attention, psychofysiological arousal

Interventions

Short-term Music therapy Attention and Arousal Regulation Treatment (SMAART) is&nbsp
a music therapy treatment protocol that focuses on improving selective and&nbsp
sustained attention and arousal regulation strategies in detainees with&nbsp
post-traumatic stress disorder (PTSD). SMAART is grounded on evidence from the&nbsp
neurobiology of trauma, neurobiology of music and (neurological) music therapy.&nbsp
SMAART is based on six therapeutic principles: (1) give psycho-education to the&nbsp
client, (2) teach the client to recognize and regulate stress reactions, (3)&nbsp
adjust the tempo of the treatment to the capacities of the client, (4) give&nbsp
feedback in the moment about and on the regulating skills of the client, (5)&nbsp
achieve repetition upon repetition to appropriate skills, and (6) monitor the&nbsp
progress of the client with validated measurements.&nbsp
Within the proposed study, we use SMAART-J: a modified version of SMAART that&nbsp
focuses on adolescents between 12 and 18 years old, who have experienced&nbsp
adverse or traumatic experiences and show deficits in their self-regulatory&nbsp
skills. The SMAART-J intervention is offered individually over a period of eight weekly&nbsp
60-minute music therapy sessions. At the start, the participant receives&nbsp
psycho-education about trauma and stress responses in the brain. Subsequently,&nbsp
various music therapy micro-interventions aimed at regulating arousal and&nbsp
training selective and sustained attention are offered. These&nbsp
micro-interventions can be offered repeatedly during the intervention period&nbsp

Sponsors

Stichting Pluryn
Lead Sponsor

Eligibility

Age
12 Years to 17 Years

Inclusion criteria

Inclusion criteria: Participant is between 12 - 18 years old at the start of the intervention  period.Participant receives treatment at one of the participating institutions for  specialized youth care and is expected to continue treatment for at least 3  months after the start of the intervention period. Participant has a score of >/= 20 on the 'Kind en Jeugd Trauma Screener '(KJTS) or has been diagnosed with Post Traumatic Stress Disorder (PTSD).Participant speaks and understands Dutch.

Exclusion criteria

Exclusion criteria: Participant has hypersensitivity to sound.Participant is simultaneously participating in another clinical trial.A negative recommendation to participate by an involved clinician (e.g., the  involved clinician expects that participation will have a negative effect on  the participant).

Design outcomes

Primary

MeasureTime frame
The SMAART-J intervention aims to reduce trauma-related symptoms as well as improve arousal regulation, and selective-, and sustained attention functions. The primary outcome measures thus focus on changes in self-reported trauma symptoms, selective- and sustained attention, and arousal through the physiological parameters heart rate variability and skin conductance.

Secondary

MeasureTime frame
Experiences of the client and feasibility of the SMAART-J intervention are secondary outcomes. For this purpose, each participant will fill out a short questionnaire consisting of 5 questions based on a 7-point likert-scale after each session during the intervention period.

Countries

Netherlands

Contacts

Public ContactT.P. Abrahams

Vrije Universiteit

tabrahams@pluryn.nl+31610569951

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jul 23, 2026